Carcinoma metastatic to cervical lymph nodes from an occult primary tumor: the outcome after combined-modality therapy
- PMID: 17508250
- DOI: 10.1245/s10434-006-9329-9
Carcinoma metastatic to cervical lymph nodes from an occult primary tumor: the outcome after combined-modality therapy
Abstract
Background: The aim of this retrospective analysis was to analyze the results of treatment of patients with cervical node metastases from carcinoma of occult primary with a policy including neck dissection and postoperative comprehensive radiotherapy.
Methods: Ninety patients were treated with curative intent from 1990 to 2002.
Results: The actuarial rate of neck disease control was 68.8% at 5 years (95% confidence interval [CI], 58.9%-78.7%). On multivariate analysis, the rate of neck disease control was significantly related to lymph nodal metastatic level (P = .006). The actuarial rate of developing head and neck primary tumors at 5 years was 8.9% (95% CI, 2.6%-15.2%). The 5-year actuarial rate of distant metastases was 19.1% (95% CI, 9.4%-28.9%). In multivariate analysis, a statistically significant difference in the rate of distant metastasis was obtained when patients were stratified according to the level of nodal involvement (P = .01) and the presence of extracapsular extension (P = .013). At the time of analysis, 50 of the 90 patients were alive. A total of 32 (35.6%) had died from causes related to their primary disease. Actuarial disease-specific survival at 2 and 5 years was 73.6% (95% CI, 64.3%-82.9%) and 62.8% (95% CI, 51.9%-73.7%), respectively. In multivariate analysis, a statistically significant difference in disease-specific survival was obtained when patients were stratified according to the level of nodal involvement and the presence of extracapsular extension.
Conclusions: Our study seems to support the use of combined-modality therapy in patients with neck metastases from carcinoma of occult primary. However, in the absence of randomized trials, comprehensive irradiation cannot be routinely advised.
Similar articles
-
[Diagnosis and treatment of 39 patients with cervical lymph node metastases of squamous cell carcinoma of unknown primary origin, referred to Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, 1979-98].Ned Tijdschr Geneeskd. 2000 Jul 8;144(28):1355-60. Ned Tijdschr Geneeskd. 2000. PMID: 10923158 Dutch.
-
Combined ipsilateral treatment of cervical lymph nodes metastases from an unknown primary.B-ENT. 2008;4(3):157-61. B-ENT. 2008. PMID: 18949962
-
Diagnosis and treatment of isolated neck metastases of adenocarcinomas.Eur J Surg Oncol. 2002 Mar;28(2):147-52. doi: 10.1053/ejso.2001.1222. Eur J Surg Oncol. 2002. PMID: 11884050
-
Neck lymph node metastases from an unknown primary tumor retrospective study and review of literature.Strahlenther Onkol. 2005 Jun;181(6):355-62. doi: 10.1007/s00066-005-1338-2. Strahlenther Onkol. 2005. PMID: 15925977 Review.
-
Contemporary management of lymph node metastases from an unknown primary to the neck: II. a review of therapeutic options.Head Neck. 2013 Feb;35(2):286-93. doi: 10.1002/hed.21899. Epub 2011 Oct 27. Head Neck. 2013. PMID: 22034062 Review.
Cited by
-
Cancer of unknown primary (CUP) of the head and neck: retrospective analysis of 81 patients.Eur Arch Otorhinolaryngol. 2017 Jun;274(6):2557-2566. doi: 10.1007/s00405-017-4525-8. Epub 2017 Mar 17. Eur Arch Otorhinolaryngol. 2017. PMID: 28314959
-
Management of neck metastases of unknown primary origin united in two European centers.Eur Arch Otorhinolaryngol. 2015 Jan;272(1):195-205. doi: 10.1007/s00405-014-2934-5. Epub 2014 Mar 11. Eur Arch Otorhinolaryngol. 2015. PMID: 24615648
-
Prognostic factors for head and neck cancer of unknown primary including the impact of human papilloma virus infection.J Otolaryngol Head Neck Surg. 2017 Jun 10;46(1):45. doi: 10.1186/s40463-017-0223-1. J Otolaryngol Head Neck Surg. 2017. PMID: 28601094 Free PMC article.
-
The prevalence of human papillomavirus in squamous cell carcinoma of unknown primary site metastatic to neck lymph nodes: a systematic review.Clin Exp Metastasis. 2015 Dec;32(8):835-45. doi: 10.1007/s10585-015-9744-z. Epub 2015 Sep 10. Clin Exp Metastasis. 2015. PMID: 26358913
-
Roles of Ki-67 and p16 as biomarkers for unknown primary head and neck squamous cell carcinoma.Eur Arch Otorhinolaryngol. 2019 Apr;276(4):1221-1229. doi: 10.1007/s00405-019-05338-3. Epub 2019 Feb 12. Eur Arch Otorhinolaryngol. 2019. PMID: 30756227
MeSH terms
LinkOut - more resources
Full Text Sources
Medical